Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Odile Launay

Showing results (151-160 of 305) with videos related to

Pageof 31
Sort By:
AIDS (London, England)|March 31, 2016
Decreased ovarian reserve in HIV-infected womenPietro Santulli, Diane de Villardi, Vanessa Gayet, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2011
Pregnancy-related effects on tenofovir pharmacokinetics: a population study with 186 womenSihem Benaboud, Déborah Hirt, Odile Launay, et al.
Human Vaccines & Immunotherapeutics|December 14, 2021
Acceptance of childhood and adolescent vaccination against COVID-19 in France: a national cross-sectional study in May 2021Pierre Verger, Patrick Peretti-Watel, Amandine Gagneux-Brunon, et al.
Clinical and Experimental Rheumatology|May 30, 2012
Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patientsAlex Kostianovsky, Pierre Charles, Jean-François Alves, et al.
Antiviral Therapy|September 9, 2011
Residual HIV-1 RNA and HIV-1 DNA production in the genital tract reservoir of women treated with HAART: the prospective ANRS EP24 GYNODYN studyOdile Launay, Michel Tod, Inga Tschöpe, et al.
Vaccine|December 11, 2007
Phase I study of a candidate vaccine based on recombinant HIV-1 gp160 (MN/LAI) administered by the mucosal route to HIV-seronegative volunteers: the ANRS VAC14 studyGilles Pialoux, Hakim Hocini, Sophie Pérusat, et al.
Plos One|August 5, 2016
Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic ReviewVincent Muturi-Kioi, David Lewis, Odile Launay, et al.
BMC Public Health|June 7, 2014
First-year results of the Global Influenza Hospital Surveillance Network: 2012-2013 Northern hemisphere influenza seasonJoan Puig-Barberà, Anita Tormos, Anna Sominina, et al.
Journal of Epidemiology and Population Health|March 20, 2025
Étude de cohorte rétrospective à l'échelle nationale visant à évaluer l'efficacité vaccinale relative du vaccin grippal haute dose par rapport aux vaccins dose standard chez les adultes de plus de 65 ans vivant en communauté en France au cours de la saison 2022-2023Hélène Bricout, Fanny Raguideau, Marie-Cécile Levant, et al.
Basic & Clinical Pharmacology & Toxicology|August 10, 2011
Pharmacogenetics of toxicity, plasma trough concentration and treatment outcome with nevirapine-containing regimen in anti-retroviral-naïve HIV-infected adults: an exploratory study of the TRIANON ANRS 081 trialClaire Gozalo, Laurence Gérard, Pascale Loiseau, et al.
Pageof 31

Showing results (151-160 of 305) with videos related to

Sort By:
Pageof 31
AIDS (London, England)|March 31, 2016
Decreased ovarian reserve in HIV-infected womenPietro Santulli, Diane de Villardi, Vanessa Gayet, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2011
Pregnancy-related effects on tenofovir pharmacokinetics: a population study with 186 womenSihem Benaboud, Déborah Hirt, Odile Launay, et al.
Human Vaccines & Immunotherapeutics|December 14, 2021
Acceptance of childhood and adolescent vaccination against COVID-19 in France: a national cross-sectional study in May 2021Pierre Verger, Patrick Peretti-Watel, Amandine Gagneux-Brunon, et al.
Clinical and Experimental Rheumatology|May 30, 2012
Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patientsAlex Kostianovsky, Pierre Charles, Jean-François Alves, et al.
Antiviral Therapy|September 9, 2011
Residual HIV-1 RNA and HIV-1 DNA production in the genital tract reservoir of women treated with HAART: the prospective ANRS EP24 GYNODYN studyOdile Launay, Michel Tod, Inga Tschöpe, et al.
Vaccine|December 11, 2007
Phase I study of a candidate vaccine based on recombinant HIV-1 gp160 (MN/LAI) administered by the mucosal route to HIV-seronegative volunteers: the ANRS VAC14 studyGilles Pialoux, Hakim Hocini, Sophie Pérusat, et al.
Plos One|August 5, 2016
Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic ReviewVincent Muturi-Kioi, David Lewis, Odile Launay, et al.
BMC Public Health|June 7, 2014
First-year results of the Global Influenza Hospital Surveillance Network: 2012-2013 Northern hemisphere influenza seasonJoan Puig-Barberà, Anita Tormos, Anna Sominina, et al.
Journal of Epidemiology and Population Health|March 20, 2025
Étude de cohorte rétrospective à l'échelle nationale visant à évaluer l'efficacité vaccinale relative du vaccin grippal haute dose par rapport aux vaccins dose standard chez les adultes de plus de 65 ans vivant en communauté en France au cours de la saison 2022-2023Hélène Bricout, Fanny Raguideau, Marie-Cécile Levant, et al.
Basic & Clinical Pharmacology & Toxicology|August 10, 2011
Pharmacogenetics of toxicity, plasma trough concentration and treatment outcome with nevirapine-containing regimen in anti-retroviral-naïve HIV-infected adults: an exploratory study of the TRIANON ANRS 081 trialClaire Gozalo, Laurence Gérard, Pascale Loiseau, et al.
Pageof 31